| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |